Relistor
These highlights do not include all the information needed to use RELISTOR safely and effectively. See full prescribing information for RELISTOR. RELISTOR (methylnaltrexone bromide) tablets, for oral use RELISTOR (methylnaltrexone bromide) injection, for subcutaneous use Initial U.S. Approval: 2008
c488fb7c-0a5b-487c-b452-996809d1cb99
HUMAN PRESCRIPTION DRUG LABEL
Dec 12, 2023
Salix Pharmaceuticals, Inc.
DUNS: 793108036
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Methylnaltrexone bromide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (1)
Methylnaltrexone bromide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
Methylnaltrexone bromide
Product Details
FDA regulatory identification and product classification information